The protective effects of tanshinone IIA on neurotoxicity induced by β-amyloid protein through calpain and the p35/Cdk5 pathway in primary cortical neurons

Neurochemistry International
Li-Li ShiYong Liu

Abstract

The characteristic pathological change of Alzheimer's disease (AD) include deposits of β-amyloid protein (Aβ) in brain, neurofibrillary tangles (NFTs), as well as a few neuronal loss. Evidence shows that Aβ causes calcium influx and induces the cleavage of p35 into p25. Furthermore, the binding of p25 to cyclin-dependent kinase 5 (Cdk5) constitutively activates Cdk5. The p25/Cdk5 complex then hyperphosphorylates tau. Tanshinone IIA (tanIIA), a natural product extracted from Chinese herbal medicine Salvia miltiorrhiza BUNGE, has been reported to exert antioxidative activity. However, its neuroprotective activity remains unclear. The present study determined whether tanIIA protects neurons against Aβ(25-35)-induced cytotoxicity and detected the association of this protective effect with calpain and the p35/Cdk5 pathway. The results showed that tanIIA protected neurons against the neurotoxicity of Aβ(25-35), increased the viability of neurons, decreased expression of phosphorylated tau in neurons induced by Aβ(25-35), improved the impairment of the cell ultrastructure (such as nuclear condensation and fragmentation, and neurofibril collapse). Further more, we found that tanIIA maintained the normal expression of p35 on peripheral ...Continue Reading

References

Sep 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·D T LooC W Cotman
Jul 9, 2004·World Journal of Gastroenterology : WJG·Shu-Lan YuanJie Zhang
Nov 18, 2005·Journal of Clinical Pharmacology·Limin ZhouMoses Sing Sum Chow
May 26, 2007·Biotechnology Journal·Sashi KesavapanyHarish C Pant
Jun 14, 2008·Proceedings of the National Academy of Sciences of the United States of America·Jie ZhangKarl Herrup

❮ Previous
Next ❯

Citations

Oct 8, 2013·PloS One·Alessandra BosuttiMark Slevin
Aug 29, 2012·Future Medicinal Chemistry·Laurent CalculBill J Baker
Oct 26, 2012·Expert Opinion on Therapeutic Patents·Xiao-Hong Tian, Jian Hui Wu
Oct 15, 2013·American Journal of Otolaryngology·Lijuan ShiYu Yang
Apr 11, 2015·Pharmaceutical Biology·Xiu-Zhen ZhangRui-Qi Wang
Aug 1, 2015·Molecular Neurobiology·Shu-Lei LiuJin-Tai Yu
Apr 22, 2015·Biomolecules·Afsaneh PorzoorIan Macreadie
Sep 14, 2017·Neuroreport·Wei Thye LeeYun-An Lim
Aug 14, 2018·Current Drug Targets·Duraiswamy BasavanMohan K S Kumar
Dec 13, 2019·Journal of Natural Medicines·Yujia LiDengke Bao
Aug 4, 2016·Reviews in the Neurosciences·Sana JavedSeyed Mohammad Nabavi
Mar 5, 2019·Metabolomics : Official Journal of the Metabolomic Society·Mingyong ZhangYifeng Chai
Nov 17, 2016·The American Journal of Chinese Medicine·Zhi-Yong WangHui-Ming Yang
Mar 20, 2019·Journal of Geriatric Psychiatry and Neurology·Li LinPing Wang
Jan 7, 2018·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Baiping RenJie Zheng
May 27, 2020·Oxidative Medicine and Cellular Longevity·Yongpan HuangPan Zhang
May 11, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Lalita Subedi, Bhakta Prasad Gaire
May 10, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Prajakta A DhageShidin Balakrishnan
Feb 24, 2019·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Miao-Juan ShiHui Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Calcium & Bioenergetics

Bioenergetic processes, including cellular respiration and photosynthesis, concern the transformation of energy by cells. Here is the latest research on the role of calcium in bioenergetics.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.